- Artikel
- Bron: Campus Sanofi
- 24 okt 2025
Understanding Autoimmune T1D & The Value of Early Detection

In 4 minutes, learn how early detection through systematic screening can reduce diabetic ketoacidosis (DKA) rates by up to 90%, how screening can reduce risk of acute complications, and how early detection of T1D can improve both short and long-term outcomes for people who develop the condition.9-11
The scientific literature is clear: identifying autoimmune T1D in its earliest stages provides critical time for early diagnosis, intervention and preparation.1-3
Early detection can transform life for those who develop autoimmune T1D and their families. Screen today for better outcomes tomorrow.
Early Detection of Autoimmune Type 1 Diabetes ((in het Nederlands)
Early Detection of Autoimmune Type 1 Diabetes (in English)
Produced by Sanofi North Europe, based on cited literature.
-
Insel RA, et al. Diabetes Care. 2015;38(10):1964-1974.
-
Ziegler AG, et al. JAMA. 2013;309(23):2473-2479.
-
Haller MJ, Bell KJ, Besser REJ et al. (2024) ISPAD Consensus Guidelines, Horm Res Paediatr 1-30
-
Bonifacio E, et al. Diabetologia. 2017;60(10):1967-1976.
-
Krischer JP, et al. Diabetologia. 2015;58(6):1310-1318.
-
Jacobsen LM, et al. Diabetes Care. 2018;41(9):1906-1913.
-
Dayan CM, Besser REJ, Oram RA et al. (2021) Science 373, pp506–10 2
-
Ozen G, Zanfardino A, Confetto S et al. (2020) Int J Endocrinol. 2020,2630827
-
Wherrett DK, et al. Diabetes Care. 2018;41(8):1669-1680.
-
Steck AK, et al. Diabetes Care. 2019;42(11):2027-2033.
-
Ziegler AG, et al. JAMA. 2020;323(4):339-351.
Neem contact op

MAT-BE-2501137-v1.0-25SEP2025